Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Four Points By Sheraton Bur Dubai

Dec 12, 2016 8:00 AM - Dec 13, 2016 5:00 PM

Khalid Bin Walid Street, Bur Dubai P.O. Box 33196, Dubai, United Arab Emirates

Practical Guide for Pharmacovigilance: Clinical Trials and Post-Marketing

Pharmacovigilance practices are emerging in the Middle East as the GCC countries are implementing new safety standards based on the European GVP modules. This course is taught by Jan Petracek, former Head of Risk Management at the EMA, with insights on GVP developments and learning any safety professional will benefit from. The course walks you through the essentials of pharmacovigilance practices in pre- and post-marketing phases to enable you hit the ground running when implementing safety reporting. </P>

Faculty

Jan  Petracek, MD, MSc

Jan Petracek, MD, MSc

CEO, iVigee Services a.s., Czech Republic

Physician and pharmacovigilance leader with more than 26 years of experience as a senior regulator, QPPV, auditor, trainer, and serial entrepreneur. Working in intelligent automation in PV for over 10 years, with the last 4 years dedicated to hands-on development and implementation of generative AI and AI agents in PV operations, including the validation of such systems and their defence before auditors and inspectors. Faculty member of DIA’s AI in PV training course and lecturer at the European Course in Pharmaceutical Medicine. Fellow of the International Society of Pharmacovigilance. Educated at Charles University in Prague, Imperial College London, with additional executive education in business and agentic AI from Harvard and MIT.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.